27
Participants
Start Date
February 4, 2013
Primary Completion Date
September 14, 2018
Study Completion Date
March 17, 2026
Dinutuximab
Given IV
Isotretinoin
Given PO
Laboratory Biomarker Analysis
Correlative studies
Lenalidomide
Given PO
Pharmacological Study
Correlative studies
Children's Hospital of Philadelphia, Philadelphia
UNC Lineberger Comprehensive Cancer Center, Chapel Hill
Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
Cincinnati Children's Hospital Medical Center, Cincinnati
C S Mott Children's Hospital, Ann Arbor
University of Chicago Comer Children's Hospital, Chicago
Cook Children's Medical Center, Fort Worth
Children's Hospital Colorado, Aurora
Children's Hospital Los Angeles, Los Angeles
UCSF Medical Center-Parnassus, San Francisco
Lucile Packard Children's Hospital Stanford University, Palo Alto
Seattle Children's Hospital, Seattle
Boston Children's Hospital, Boston
Dana-Farber Cancer Institute, Boston
Hospital for Sick Children, Toronto
National Cancer Institute (NCI)
NIH